Eli Lilly signed a drug discovery deal with InSilico that the Hong Kong-listed company says could be valued at as much as $2.75 billion, as global pharmaceutical giants continue to tap China’s drug ...

China has been consolidating an ambition to build a world-class pharmaceutical industry. With the emergence of new technologies, collaboration paradigms, and institutional support, the next natural ...